McKesson is engaged in healthcare services. Co. operates its business in four reportable segments: U.S. Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; Prescription Technology Solutions, which provides prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support; Medical-Surgical Solutions, which provides medical-surgical supply distribution, logistics, and other services to healthcare providers; and International, which provides distribution and services to wholesale, institutional, and retail customers. The MCK stock yearly return is shown above.
The yearly return on the MCK stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the MCK annual return calculation with any dividends reinvested as applicable (on ex-dates).
|